Smoldering and Spiking: Mapping MS and Modern DMTs

Multiple sclerosis (MS) is increasingly understood as a spectrum in which relapsing activity and progression can overlap, creating a need for smart, individualized use of disease-modifying therapies. Listen in to learn from Patricia K. Coyle, MD, FAAN, FANA, for a practical review of today’s MS DMT options, with a focus on high-efficacy monoclonal antibodies such as anti-CD20 therapies, how healthcare professionals think about progression concepts like PIRA and RAW, and what emerging trial designs like OCTOPUS may mean for improving treatment options in progressive MS.

Presenter:

Patricia K. Coyle, MD, FAAN, FANA Distinguished Professor of Neurology Vice Chair for Academic Affairs Department of Neurology Stony Brook Renaissance School of Medicine Director, MS Comprehensive Care Center Stony Brook, New York

Link to full program:https://bit.ly/3PdRks4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.